Related Experiment Video
Updated: Jun 23, 2026
14:35
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Prevention of heart failure progression: current approaches
1Pharmacology Department, Pitié-Salpétrière Hospital, Paris, France.
European Heart Journal
|March 31, 1998
Summary
Heart failure stems from myocardial damage. Therapies aim to reduce cardiac load and block detrimental neurohormonal effects, with ongoing trials seeking optimal prevention strategies for heart failure progression.
Area of Science:
- Cardiology
- Pathophysiology
- Pharmacology
Background:
- Heart failure arises from myocardial damage and stress, regardless of the cause.
- Compensatory mechanisms, including the sympathetic nervous system and renin-angiotensin-aldosterone system, initially manage cardiac overload but can lead to myocyte dysfunction and fibrosis.
- Progressive cell death and fibrous tissue replacement characterize advanced heart failure.
Purpose of the Study:
- To outline the pathophysiology of heart failure.
- To discuss current therapeutic strategies for managing heart failure.
- To highlight the potential of complete neurohormonal blockade as a future therapeutic goal.
Main Methods:
- Review of existing literature on heart failure mechanisms and treatments.
- Analysis of the roles of neurohormonal systems in cardiac remodeling.
- Discussion of pharmacological interventions, including diuretics, vasodilators, and adrenergic blockade.
Main Results:
- Compensatory mechanisms in heart failure can paradoxically promote disease progression.
- Current therapies focus on reducing cardiac workload and mitigating adverse neurohormonal effects.
- Complete blockade of detrimental neurohormonal pathways is a promising therapeutic objective.
Conclusions:
- Effective heart failure management requires reducing cardiac loading and avoiding therapies that exacerbate the condition.
- Targeting neurohormonal pathways involved in adverse cardiac remodeling is crucial for improving prognosis.
- Ongoing clinical trials are essential to establish definitive treatment protocols for preventing heart failure progression.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...